Enliven Therapeutics, Inc. (ELVN)
54.32
-1.91
(-3.40%)
USD |
NASDAQ |
Sep 11, 16:00
54.29
-0.03
(-0.06%)
After-Hours: 20:00
Enliven Therapeutics Price : 54.32 for Sept. 11, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 57.00 | 57.00 | 54.12 | 54.32 | 995816.0 |
| Sep 10, 2026 | 57.15 | 57.82 | 56.05 | 56.23 | 769641.0 |
| Sep 09, 2026 | 59.05 | 59.96 | 57.29 | 57.45 | 1.294M |
| Sep 08, 2026 | 58.75 | 59.90 | 58.24 | 59.37 | 1.326M |
| Sep 04, 2026 | 59.69 | 59.89 | 58.96 | 59.32 | 1.113M |
| Sep 03, 2026 | 58.88 | 60.10 | 58.66 | 59.65 | 806070.0 |
| Sep 02, 2026 | 58.36 | 60.55 | 57.36 | 59.01 | 609969.0 |
| Sep 01, 2026 | 57.99 | 58.45 | 57.23 | 57.86 | 1.056M |
| Aug 31, 2026 | 57.50 | 58.78 | 56.33 | 57.89 | 982051.0 |
| Aug 28, 2026 | 60.40 | 61.18 | 57.73 | 57.86 | 584982.0 |
| Aug 27, 2026 | 60.76 | 61.82 | 60.46 | 60.50 | 524066.0 |
| Aug 26, 2026 | 61.02 | 61.80 | 59.79 | 60.86 | 1.001M |
| Aug 25, 2026 | 61.90 | 62.00 | 60.57 | 61.01 | 804387.0 |
| Aug 24, 2026 | 59.77 | 61.99 | 59.47 | 61.15 | 1.255M |
| Aug 21, 2026 | 59.00 | 60.00 | 58.83 | 59.82 | 596369.0 |
| Aug 20, 2026 | 58.95 | 59.54 | 57.07 | 58.92 | 945520.0 |
| Aug 19, 2026 | 61.01 | 61.21 | 58.39 | 59.39 | 939740.0 |
| Aug 18, 2026 | 59.79 | 60.44 | 59.01 | 60.07 | 619313.0 |
| Aug 17, 2026 | 58.71 | 59.65 | 57.92 | 59.54 | 529480.0 |
| Aug 14, 2026 | 57.67 | 58.90 | 56.69 | 58.82 | 350291.0 |
| Aug 13, 2026 | 58.54 | 58.73 | 57.70 | 58.06 | 595094.0 |
| Aug 12, 2026 | 59.09 | 60.38 | 57.68 | 57.92 | 1.011M |
| Aug 11, 2026 | 59.25 | 59.27 | 57.39 | 58.78 | 1.277M |
| Aug 10, 2026 | 59.89 | 60.99 | 58.52 | 59.42 | 620957.0 |
| Aug 07, 2026 | 60.18 | 61.76 | 59.73 | 60.46 | 696068.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Cocrystal Pharma, Inc. | 1.24 |
| CNBX Pharmaceuticals, Inc. | 0.0001 |
| GB Sciences, Inc. | 0.0002 |
| Arvinas, Inc. | 8.45 |
| Fulcrum Therapeutics, Inc. | 3.80 |
Price Related Metrics
| Price to Book Value | 4.445 |
| Earnings Yield | -3.07% |
| Market Cap | 3.979B |